Cite
Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.
MLA
Ferrer, Miriam, et al. “Chemosensitizing Tumor Cells by Targeting the Fanconi Anemia Pathway with an Adenovirus Overexpressing Dominant-Negative FANCA.” Cancer Gene Therapy, vol. 11, no. 8, Aug. 2004, pp. 539–46. EBSCOhost, https://doi.org/10.1038/sj.cgt.7700734.
APA
Ferrer, M., de Winter, J. P., Masterbroek, D. C. J., Curiel, D. T., Gerritsen, W. R., Giaccone, G., & Kruyt, F. A. E. (2004). Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA. Cancer Gene Therapy, 11(8), 539–546. https://doi.org/10.1038/sj.cgt.7700734
Chicago
Ferrer, Miriam, Johan P. de Winter, D.C. Jeroen Masterbroek, David T. Curiel, Winald R. Gerritsen, Giuseppe Giaccone, and Frank A.E. Kruyt. 2004. “Chemosensitizing Tumor Cells by Targeting the Fanconi Anemia Pathway with an Adenovirus Overexpressing Dominant-Negative FANCA.” Cancer Gene Therapy 11 (8): 539–46. doi:10.1038/sj.cgt.7700734.